Study Title
RELIVE: International registry for paediatric patients with a relapsed or refractory hepatoblastoma or hepatocellular carcinoma
Protocol ID
RELIVE
Condition/s
Hepatoblastoma
Hepatocellular carcinoma
Hepatocellular carcinoma
Location
NSW, QLD, WA
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Trial Status
Closed to Recruitment
Trial Close Date
30/11/2023
Sites
Perth Children's Hospital
Queensland Children's Hospital
John Hunter Children's Hospital
The Children's Hospital at Westmead
Women's and Children's Hospital
Queensland Children's Hospital
John Hunter Children's Hospital
The Children's Hospital at Westmead
Women's and Children's Hospital
Study Type
Registry
Phase
Not applicable
Age Eligibility
Up to 18 Years
| Study Title | RELIVE: International registry for paediatric patients with a relapsed or refractory hepatoblastoma or hepatocellular carcinoma |
|---|---|
| Protocol ID | RELIVE |
| Disease (Sub Disease) | Hepatoblastoma Hepatocellular carcinoma |
| Location | NSW / QLD / WA |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 01/05/2023 |
| Trial Close Date | 30/11/2023 |
| Sites | Perth Children's Hospital/ Queensland Children's Hospital / John Hunter Children's Hospital / The Children's Hospital at Westmead / Women's and Children's Hospital |
| Study Type | Registry |
| Phase | Not applicable |
| Age Eligibility | Up to 18 Years |